Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Clinical trial NCT02551432 · COMPLETED
Trial details
- NCT number
- NCT02551432
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.